These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34175943)

  • 21. Integrating molecular interactions and gene expression to identify biomarkers to predict response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients.
    He MF; Liang Y; Huang HH
    Technol Health Care; 2022; 30(S1):451-457. PubMed ID: 35124619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.
    Myasoedova E; Athreya AP; Crowson CS; Davis JM; Warrington KJ; Walchak RC; Carlson E; Kalari KR; Bongartz T; Tak PP; van Vollenhoven RF; Padyukov L; Emery P; Morgan A; Wang L; Weinshilboum RM; Matteson EL;
    Arthritis Care Res (Hoboken); 2022 Jun; 74(6):879-888. PubMed ID: 34902228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in the metabolome in response to disease activity of rheumatoid arthritis.
    Tatar Z; Migne C; Petera M; Gaudin P; Lequerre T; Marotte H; Tebib J; Pujos Guillot E; Soubrier M
    BMC Musculoskelet Disord; 2016 Aug; 17(1):353. PubMed ID: 27549132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients.
    Prasad B; McGeough C; Eakin A; Ahmed T; Small D; Gardiner P; Pendleton A; Wright G; Bjourson AJ; Gibson DS; Shukla P
    PLoS Comput Biol; 2022 Jul; 18(7):e1010204. PubMed ID: 35788746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF.
    Song YJ; Choi IA; Meylan F; Demoruelle MK; Farley T; Richard AC; Hawley E; Botson J; Hong YJ; Lee EY; Mian SR; Hamilton BC; Thiele GM; Mikuls TR; Gara N; Ward CD; Lamberth S; Deane KD; Heller T; Ward MM; Lee DM; Migone TS; Stohl W; O'Dell JR; Norris JM; Holers VM; Gregersen P; Song YW; Siegel RM
    Arthritis Res Ther; 2020 May; 22(1):106. PubMed ID: 32381123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis.
    Artacho A; Isaac S; Nayak R; Flor-Duro A; Alexander M; Koo I; Manasson J; Smith PB; Rosenthal P; Homsi Y; Gulko P; Pons J; Puchades-Carrasco L; Izmirly P; Patterson A; Abramson SB; Pineda-Lucena A; Turnbaugh PJ; Ubeda C; Scher JU
    Arthritis Rheumatol; 2021 Jun; 73(6):931-942. PubMed ID: 33314800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Changes over a Short Period Are Associated with Functional Assessments in Rheumatoid Arthritis.
    Shimizu T; Cruz A; Tanaka M; Mamoto K; Pedoia V; Burghardt AJ; Heilmeier U; Link TM; Graf J; Imboden JB; Li X
    J Rheumatol; 2019 Jul; 46(7):676-684. PubMed ID: 30770506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
    Haroon N; Srivastava R; Misra R; Aggarwal A
    J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA sequencing to predict response to TNF-α inhibitors reveals possible mechanism for nonresponse in smokers.
    Cuppen BVJ; Rossato M; Fritsch-Stork RDE; Concepcion AN; Linn-Rasker SP; Bijlsma JWJ; van Laar JM; Lafeber FPJG; Radstake TR;
    Expert Rev Clin Immunol; 2018 Jul; 14(7):623-633. PubMed ID: 29808722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunological biomarker to predict MTX response in early RA.
    Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
    Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis.
    Maillefert JF; Puéchal X; Falgarone G; Lizard G; Ornetti P; Solau E; Legré V; Lioté F; Sibilia J; Morel J; Maynadié M;
    Joint Bone Spine; 2010 Dec; 77(6):558-63. PubMed ID: 20478729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
    Carini C; Hunter E; ; Ramadass AS; Green J; Akoulitchev A; McInnes IB; Goodyear CS
    J Transl Med; 2018 Jan; 16(1):18. PubMed ID: 29378619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.
    Obry A; Lequerré T; Hardouin J; Boyer O; Fardellone P; Philippe P; Le Loët X; Cosette P; Vittecoq O
    PLoS One; 2014; 9(12):e115800. PubMed ID: 25546405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.
    Nguyen MVC; Baillet A; Romand X; Trocmé C; Courtier A; Marotte H; Thomas T; Soubrier M; Miossec P; Tébib J; Grange L; Toussaint B; Lequerré T; Vittecoq O; Gaudin P
    Joint Bone Spine; 2019 Mar; 86(2):195-201. PubMed ID: 29885551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasets.
    Kim TH; Choi SJ; Lee YH; Song GG; Ji JD
    Joint Bone Spine; 2014 Jul; 81(4):325-30. PubMed ID: 24561023
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Iwaszko M; Wielińska J; Świerkot J; Kolossa K; Sokolik R; Bugaj B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
    Front Immunol; 2021; 12():631603. PubMed ID: 34177886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.